• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec18
Femasys Inc. Obtains FDA Approval for FemVue Controlled Device
14:15
Nov15
Femasys released FY2025 9 Months Earnings on November 14, 2025 (EST) with actual revenue of USD 1.48 M and EPS of USD -0.4955
04:00
Femasys released FY2025 Q3 earnings on November 14 (EST), actual revenue USD 729.39K (forecast USD 1.35M), actual EPS USD -0.1022 (forecast USD -0.115)
04:00
Nov3
Femasys Inc. Obtains FDA Approval to Commence Recruitment for FINALE Trial's Final Stage
13:30
Aug9
Femasys released FY2025 Semi-Annual earnings on August 8 (EST), actual revenue USD 750.53K, actual EPS USD -0.3878
03:00
Femasys released FY2025 Q2 earnings on August 8 (EST), actual revenue USD 409.27K (forecast USD 1.169M), actual EPS USD -0.16 (forecast USD -0.1625)
03:00

Schedules & Filings

Schedules
Filings
Nov14
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 729.39 K, Net Income -4.195 M, EPS -0.1022

Aug8
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 409.27 K, Net Income -4.586 M, EPS -0.1587

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 341.26 K, Net Income -5.897 M, EPS -0.2344

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
RPGL
0.6834
+159.55%
+0.420
BNAI
2.505
+108.75%
+1.305
SOPA
2.930
+60.99%
+1.110
ILAG
0.5237
+48.91%
+0.172
MASK
0.2606
+42.40%
+0.078
GVH
3.560
+36.92%
+0.960
CCTG
0.1750
+34.31%
+0.045
SIDU
2.570
+33.16%
+0.640
THH
22.390
+32.21%
+5.455
TDIC
0.2566
+28.94%
+0.058
View More